You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DUTOPROL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dutoprol, and when can generic versions of Dutoprol launch?

Dutoprol is a drug marketed by Concordia and is included in one NDA.

The generic ingredient in DUTOPROL is hydrochlorothiazide; metoprolol succinate. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; metoprolol succinate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DUTOPROL?
  • What are the global sales for DUTOPROL?
  • What is Average Wholesale Price for DUTOPROL?
Summary for DUTOPROL
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 78
Drug Prices: Drug price information for DUTOPROL
What excipients (inactive ingredients) are in DUTOPROL?DUTOPROL excipients list
DailyMed Link:DUTOPROL at DailyMed
Drug patent expirations by year for DUTOPROL
Drug Prices for DUTOPROL

See drug prices for DUTOPROL

US Patents and Regulatory Information for DUTOPROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia DUTOPROL hydrochlorothiazide; metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 021956-001 Aug 28, 2006 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Concordia DUTOPROL hydrochlorothiazide; metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 021956-002 Aug 28, 2006 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Concordia DUTOPROL hydrochlorothiazide; metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 021956-003 Aug 28, 2006 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.